Trial Profile
Imaging of Cognition, Learning, and Memory in Aging
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- 30 Oct 2017 Status changed from recruiting to completed.
- 24 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2021.
- 24 Aug 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.